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Summary
Crosspresentation of exogenous antigens (Ags) to
CD8+ T cells by dendritic cells generally requires their
entry into the cytosol. Here we show that both soluble
and phagocytosed extracellular Ags accessed the
cytosol via molecular components required for endo-
plasmic reticulum (ER)-associated degradation
(ERAD). Exogenous Pseudomonas aeruginosa Exo-
toxin A, which inhibits protein translocation from the
ER to the cytosol, abrogated crosspresentation. Exo-
toxin A also prevented the transporter associated
with antigen processing (TAP) inhibitor, ICP47, from
entering the cytosol and blocking TAP-mediated pep-
tide transport. In an in vitro model of retrotransloca-
tion, the AAA ATPase p97, an enzyme critical for
ERAD, was the only cytosolic cofactor required for
protein export from isolated phagosomes. Functional
p97 was also required for crosspresentation but not
conventional presentation. Thus, crosspresentation
appears to result from an adaptation of the retrotrans-
location mechanisms involved in the degradation of
misfolded ER proteins.
Introduction
Cytotoxic T cells recognize peptides derived from viral
proteins bound to major histocompatibility complex
(MHC) class I molecules on the surface of infected cells.
These peptides are conventionally generated by protea-
somal proteolysis of newly synthesized cytoplasmic
proteins and transported into the endoplasmic reticu-
lum (ER) by TAP, which associates with nascent MHC
class I-b2microglobulin (b2m) heterodimers in a multi-
meric assembly that facilitates the formation of MHC
class I-peptide complexes (Cresswell et al., 2005).
Once generated, peptide-MHC complexes exit the ER
for display at the cell surface. During infection, peptides
derived from pathogens occupy the MHC class I binding
groove, facilitating the recognition and destruction of
infected cells by CD8+ T cells.
Before they can destroy infected cells, naive CD8+ T
cells must be ‘‘crossprimed’’ with peptides presented
in association with MHC class I molecules on the surface
of professional APCs, commonly dendritic cells (DCs).
Mature DCs express high amounts of MHC class I and
II, as well as costimulatory and adhesion molecules
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responses can be efficiently generated against patho-
gens that fail to infect DCs, as well as cellular pathogens
that never reach the cytosol (da Conceicao-Silva et al.,
1994; Kaleab et al., 1990; Romero et al., 1989; Szalay
et al., 1994). DCs therefore probably acquire patho-
gen-derived antigens (Ags) through internalization of
infected cell debris. Crosspriming, or crosspresenta-
tion, by these DCs requires a specialized pathway that
allows such Ags to access the MHC class I peptide-
loading machinery.
Substantial evidence suggests that Ags must reach
the cytosol for efficient crosspresentation. The process
is sensitive to defects in both proteasomal and TAP
function (Huang et al., 1996; Kovacsovics-Bankowski
and Rock, 1995; Norbury et al., 1995), indicating that epi-
topes are generated in the cytoplasm and transported
into the ER by TAP. Proteins can reach the cytoplasm
of DCs with large domain structures intact, although
the species detected may be subjected to partial pro-
teolysis (Rodriguez et al., 1999). The molecular machin-
ery facilitating this transport step, however, remains
undefined.
Published evidence suggests that phagosome forma-
tion involves the fusion of the ER with the plasma mem-
brane (Gagnon et al., 2002). While this process may
have originated to preserve cell surface area (Muller-
Taubenberger et al., 2001), in DCs it may facilitate the
translocation of internalized proteins into the cytosol.
Misfolded proteins are retrotranslocated from the ER
into the cytosol for degradation, and the precise mecha-
nisms involved are under intense investigation. Genetic
evidence from yeast supports the involvement of the
sec61 pore complex, as well as additional ER compo-
nents (Kiser et al., 2001; Nishikawa et al., 2001). Sec61
is a multimeric channel that cotranslationally inserts
secretory or transmembrane polypeptides into the ER
lumen. However, it may also operate in reverse to remove
misfolded proteins from the ER. An additional protein,
Derlin-1, is implicated in retrotranslocation in mamma-
lian cells (Lilley and Ploegh, 2004; Ye et al., 2004). Der-
lin-1 is homologous to a yeast protein also implicated
in retrotranslocation (Hitt and Wolf, 2004; Kirst et al.,
2005), and it has been found to associate with peptide-
N-glycanase at the ER membrane, suggesting its poten-
tial role in recruiting cytosolic deglycosylating enzymes
(Katiyar et al., 2005). However, the functional relationship
between Derlin-1 and sec61 in retrotranslocation is still
unclear.
Retrotranslocated proteins are degraded in the cyto-
sol by the proteasome, to complete the process of ER-
associated degradation (ERAD) (reviewed in McCracken
and Brodsky, 2003). Because exogenous Ags may en-
counter an ER-containing compartment during phago-
cytosis and because soluble proteins can access the
true ER in DCs (Ackerman et al., 2005), we and others
have postulated that the retrotranslocation mechanisms
involved in ERAD may be the same as those involved in
crosspresentation. Here we report results that support
this hypothesis.
Immunity
608Figure 1. Exogenous ICP47 (1-35) Abrogates the Presentation of Exogenous and Cytosolic Ags
(A) KG1.Kb cells were incubated for 16 hr with 10 mg/ml OVA (bold lines) or BSA (thin lines) in the presence of the indicated concentrations of
ICP47 (1-35) or control ICP47 (35-1) peptide. The generation of Kb-SIINFEKL complexes was assessed by flow cytometry with the 25D1.16
mAb specific for the complex.
(B) The effect of ICP47 (1-35) on the crosspresentation of OVA by KG-1.Kb was examined by means of IL-2 secretion, measured by ELISA, by B3Z
hybridoma cells, which also recognize the Kb-SIINFEKL complex. The graphs show the mean values (6 SD) from three independent experiments.
(C) Surface expression of Kb and HLA-DR was measured by flow cytometry with the mAbs Y3 and L243, respectively, on KG-1.Kb cells incubated
for 12 hr in 100 mM ICP47 (1-35) (solid line) or ICP47 (35-1) (dotted line). The dashed line indicates the isotype control.
(D) KG1.Kb (left) and PeCr2.Kb (right) cells were infected with VSV-OVA in the presence of ICP47 peptides. ICP47 (35-1)-treated (solid lines) and
ICP47 (1-35)-treated (dotted lines) cells were assessed for generation of the Kb-SIINFEKL epitope after 12 hr by flow cytometry with the 25D1.16
mAb. The dashed line indicates the isotype control.
(E) Presentation of cytosolic OVA by KG1.Kb and PeCr2.Kb was quantitated over the course of VSV-OVA infection by 25D.16 staining. Values are
expressed as a percent of the maximum signal seen in untreated cells.
(F) Inhibition of endogenous OVA presentation was confirmed with the B3Z hybridoma with VSV-OVA-infected KG1.Kb cells fixed at 0, 8, 12, and
16 hr postinfection. IL-2 released was quantitated by ELISA. Graphs show the mean values (6 SD) from three independent experiments. ICP47
(35-1)-treated and ICP47 (1-35)-treated samples are shown as light gray and dark gray bars. All results are representative of at least three
experiments.Results
Exogenous ICP47 (1-35) Abrogates
Crosspresentation of an Exogenous Ag
DuringHerpes simplex virus-1 (HSV-1) infection, the viral
ICP47 protein disrupts peptide translocation by inter-
acting with the cytosolic face of TAP. This property is
maintained by a synthetic peptide corresponding to
the N-terminal 35 amino acid residues (ICP47 (1-35))
(Galocha et al., 1997). We previously showed that an ex-
ternally added 21-residue peptide derived from the HIV
nef protein containing an embedded HLA-A3 binding
epitope could access the cytosol of DCs (Ackerman
et al., 2003). Because ICP47 (1-35) is also a small pep-
tide, we postulated that it might follow the same path-
way into the cytosol of DCs and inhibit TAP functionand thus crosspresentation. We assessed the impact
of ICP47 (1-35) on crosspresentation of an exogenous
antigen, ovalbumin (OVA), by the human dendritic-like
cell line (DLC) KG1.Kb. This cell line can internalize
OVA and crosspresent an OVA peptide (SIINFEKL) asso-
ciated with Kb (Ackerman et al., 2003). When ICP47
(1-35) was given to KG1.Kb cells concurrently with OVA,
we observed a dose-dependent inhibition of SIINFEKL
(OVA(257-264)) peptide presentation, measured with a
mAb that recognizes Kb-SIINFEKL complexes (Fig-
ure 1A). A control peptide with the reverse amino acid
sequence (ICP47 (35-1)) had no effect. These results
were confirmed with the B3Z hybridoma, which recog-
nizes the same peptide-MHC complex (Figure 1B). Nei-
ther peptide affected cell viability, the presentation of
exogenous SIINFEKL peptide, or the surface expression
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609of HLA-DR (Figure 1C). There was also no effect on Kb
surface expression, consistent with earlier findings that
mouse Kb molecules are well expressed on TAP-nega-
tive human cells (Alexander et al., 1989; Wei and Cress-
well, 1992). Thus, the crosspresentation pathway allows
exogenous ICP47 (1-35) to enter the cytosol and inhibit
presentation of exogenous OVA.
Exogenous ICP47 (1-35) Inhibits Endogenous
Ag Presentation in Dendritic Cells
If ICP47 (1-35) is retrotranslocated into the cytosol to
block TAP, it should also affect presentation of endoge-
nous cytosolic Ag. We therefore examined its effect on
the presentation of a virally encoded Ag by crosspre-
senting and noncrosspresenting cells. KG1.Kb DLCs
and a Kb-expressing human B cell line, PeCr2.Kb, were
incubated with ICP47 (1-35) during infection with vesic-
ular stomatitis virus expressing recombinant OVA (VSV-
OVA). Addition of ICP47 (1-35) specifically inhibited the
presentation of the endogenously expressed OVA by
KG1.Kb DLCs, as assessed by both flow cytometry (Fig-
ures 1D and 1E, left) and stimulation of the B3Z hybrid-
oma (Figure 1F). The PeCr2.Kb B cell line was minimally
affected (Figures 1D and 1E, right). Thus, treatment with
ICP47 (1-35) inhibits the presentation of an endogenous
cytosolic Ag only in cells capable of crosspresentation.
Exogenous ICP47 (1-35) Downregulates Surface
Expression of MHC Class I in Dendritic Cells
Cytosolic expression of ICP47 blocks TAP and reduces
surface MHC class I expression (Hughes et al., 1997).
We hypothesized that entry of ICP47 (1-35) into the cyto-
sol of crosspresenting cells should also reduce MHC
class I surface expression. ICP47 (1-35) and the control
peptide ICP47 (35-1) were added to primary human B
cells, monocyte-derived macrophages and immature
DCs, KG-1 DLCs, and the PeCr2 human B cell line.
ICP47 (1-35), but not ICP47 (35-1), induced a dose-
dependent downregulation of surface MHC class I ex-
pression when added to primary immature DCs (Fig-
ure 2A) but not when added to macrophages or B cells
(Figure 2B). Surface expression was also specifically re-
duced by ICP47 (1-35) on KG-1 DLCs (Figure 2C) but not
on the PeCr2 B cell line (Figure 2B, right). Surface ex-
pression of HLA-DR and transferrin receptor in all cells
remained unaltered (data not shown). Figure 2D shows
quantitation of the MHC class I downregulation induced
by ICP47 (1-35) in DCs, and the lack of an effect of the
control peptide. Overall, the data indicate that ICP47
(1-35) can reach the cytosol and block TAP only in cells
of DC lineage.
ER Recruitment to Phagosomes and Inhibition of
TAP-Mediated Peptide Transport by Exogenous
ICP47 (1-35)
It has been proposed that the ER is a membrane donor
to nascent phagosomes (Houde et al., 2003). To confirm
this, we used as a phagocytosis substrate microspheres
with a covalently coupled glycosylation acceptor pep-
tide. If such microspheres have access to ER luminal
components, they should be N-glycosylated by the ER
glycosylation machinery. Consistent with this expecta-
tion, microspheres isolated 15 min after phagocytosis
by KG-1 cells could be stained with fluorescent Con A,as detected by flow cytometry (Figure 3A). No Con A
binding was observed to phagocytosed microspheres
coupled to a peptide lacking consensus glycosylation
acceptor sites. As an additional control, KG-1 cells
were incubated with tunicamycin, which inhibits N-
glycosylation, prior to phagocytosis of the glycosyla-
tion-competent microspheres. This abrogated Con A
binding. No glycosylation was observed for micro-
spheres added at the time of lysis (see Figure S1A in
the Supplemental Data available online). In addition,
primary human DCs were also capable of microsphere
glycosylation (Figure S1B). These data confirm that the
ER-resident glycosylation machinery is recruited to
phagosomes.
Figure 2. Exogenous ICP47 (1-35) Downregulates Surface MHC
Class I in Crosspresenting Cells
(A–C) Immature DCs (A), macrophages, primary B cells, or the PeCr2
B cell line (B), or KG-1 DLCs (C) were incubated with the indicated
concentrations of ICP47 (1-35) (thick lines) or the control ICP47
(35-1) peptide (thin lines) for 16 hr at 37C then analyzed by flow
cytometry for MHC class I surface expression. The dashed lines
show isotype control staining.
(D) Quantitation of MHC class I surface expression by DCs (squares),
macrophages (circles), and B cells (triangles) incubated with differ-
ent concentrations of ICP47 (1-35) (open symbols) or the control
ICP47 (35-1) peptide (closed symbols). The values represent the
means (6 SD) of triplicate samples. All results are representative
of at least three experiments.
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(A) KG-1 cells were incubated for 15 min with microspheres coupled to a glycosylation acceptor peptide (solid line) or a control peptide (gray line).
Glycosylation of the microspheres was determined by flow cytometry after detergent lysis of cells, staining with Con A-Alexa 647. The dotted line
shows Con A binding to glycosylation acceptor microspheres isolated after phagocytosis by KG-1 cells pretreated with tunicamycin.
(B) Phagosomes purified from KG-1 DLCs incubated for 15 min with latex beads and ICP47 (1-35) (closed circles) or ICP47 (35-1) (open squares)
were further incubated with an 125I-labeled glycosylation acceptor peptide for the indicated times.
(C and D) TAP-translocated glycosylated peptides were recovered with Con A-Sepharose beads and counted in a g counter. TAP translocation
by (C) purified microsomes from the KG-1 cells and (D) the cells after SLO permeabilization was examined as in (B). Bound peptide recovered in
the presence of 5 U/ml apyrase (gray line) served as a negative control. All results are representative of at least three independent experiments.To determine whether prior internalization of ICP47
could affect TAP-mediated peptide import into purified
phagosomes (Ackerman et al., 2003), KG-1 cells were
allowed to internalize exogenous ICP47 (1-35) or ICP47
(35-1) for 15 min in the presence of latex beads, and
phagosomes were isolated. After washing, an 125I-
labeled glycosylation substrate peptide (nef7B) was in-
cubated with the phagosomes in the presence of an
ATP-regenerating system, required for TAP-dependent
peptide translocation (Ackerman et al., 2003). Glycosy-
lated peptides were isolated with Con A-Sepharose
beads; binding indicates transport and glycosylation of
the peptide by ER enzymes present in the phagosomes.
Pretreatment of KG-1 cells with ICP47 (1-35), but not the
control peptide, markedly inhibited phagosomal peptide
import (Figure 3B). Abrogation of peptide glycosylation
by the ATPase apyrase indicated that import was ATP
dependent. As previously described (Ackerman et al.,
2003), adding ICP47 (1-35) to phagosomes isolated
from untreated KG-1, thus providing the inhibitor with
direct access to the cytosolic face of TAP, also abro-
gated peptide import (data not shown).
ICP47 must access the cytosolic face of TAP to block
peptide translocation, and after retrotranslocation it
should diffuse freely and interact with all cellular TAP
molecules. As expected, exogenous ICP47 (1-35) in-
hibited ER-based peptide translocation in microsomes
purified from the treated KG-1 cells (Figure 3C). To en-
sure that the effects were not mediated by TAP binding
after the release of accumulated ICP47 (1-35) peptide
upon cell disruption, we measured translocation in
whole cells after specific permeabilization of the plasma
membrane with Streptolysin-O (SLO) (Figure 3D). We
again observed specific inhibition. These data support
a model in which the exogenous inhibitor freely diffuses
throughout the cell.
ExoA Reverses ICP47-Mediated TAP Inhibition
Sec61 has been implicated in the retrotranslocation of
proteins from the ER, and the bacterial exotoxin from
Pseudomonas aeruginosa, Exotoxin A (ExoA), has
been shown to reversibly inhibit retrotranslocation via
the sec61 channel (Koopmann et al., 2000). Fluid phase
proteins, including b2m and the human cytomegalovirus
protein US6, can reach the ER directly in DCs and in theDC-like cell line KG-1 (Ackerman et al., 2005), and we hy-
pothesized that ExoA might do the same. To confirm the
internalization of ExoA, microsomes were isolated from
KG-1 cells after incubation with ExoA at 37C. After de-
tergent solubilization and immunoprecipitation by an
antibody to ExoA, immunoblotting with biotinylated
ExoA Ab showed the presence of the 66 kDa full-length
protein and two proteolytic fragments of 37 and 28 kDa
generated intracellularly, as previously described (Fig-
ure 4A; Ogata et al., 1990). To assess the potential inter-
action of internalized ExoA with the ER retrotransloca-
tion machinery, we focused on the AAA ATPase, p97,
a known component of this system. Microsomes from
KG-1 cells treated with ExoA were incubated with re-
combinant biotinylated p97, washed, and then solubi-
lized in digitonin containing the reducible crosslinker
DSP. Biotinylated p97 and associated components
were isolated with streptavidin-agarose beads and sub-
jected to reducing SDS-PAGE and immunoblotting. In-
ternalized ExoA clearly associated with p97 but not
with exogenous recombinant biotinylated GST used as
control (Figure 4B). No association was observed when
biotinylated p97-treated microsomes were mixed with
ExoA-containing microsomes before lysis and crosslink-
ing. The ExoA-p97 interaction was specific, as shown
by the fact that no crosslinking of ExoA with MHC class
I molecules or the ribosomal protein, L22, was observed
(Figure 4B). The results suggest that in DCs, exogenous
proteins are translocated from the ER into the cytosol
by molecular components required for ERAD. To test
whether ICP47 (1-35) used the same retrotranslocation
mechanism, we purified phagosomes from ICP47 (1-35)-
treated cells, in this case adding ExoA and ICP47 (1-35)
to the latex beads prior to phagocytosis by KG-1 cells.
ExoA markedly reversed the inhibition of TAP activity
mediated by ICP47 (1-35), restoring substrate transloca-
tion to near untreated levels (Figure 4C). The results are
consistent with the hypothesis that exogenous ICP47
(1-35) and protein antigens access the cytosol via the
sec61 channel.
Exogenous ExoA Inhibits Crosspresentation
The preceding data suggested that ExoA should also in-
hibit the transport of exogenous Ags into the cytoplasm.
To test this hypothesis, we incubated KG1.Kb cells with
ERAD Mechanisms and Crosspresentation
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(A) Cell lysates from KG-1 cells incubated with 30 mg/ml ExoA for 2 hr were subjected to immunoprecipitation (IP) with ExoA Ab (ExoA) or control
serum (Cont) followed by SDS-PAGE under nonreducing (2DTT) or reducing (+DTT) conditions and the samples immunoblotted with biotinylated
ExoA Ab. Recombinant ExoA (rExoA) was included as a positive control (lane 4).
(B) Microsomes from KG-1 cells incubated with or without ExoA (30 mg/ml) for 2 hr were incubated with recombinant biotinylated p97 or GST (as
a control) for 1 hr at 4C. Pelleted microsomes were solubilized in digitonin containing the crosslinker DSP. As a control (lane 6), microsomes
containing ExoA were mixed with microsomes incubated with biotinylated p97 during solubilization and crosslinking. p97 was isolated with
streptavidin-agarose, and potential crosslinked components were detected by immunoblotting with Abs to ExoA, MHC class I heavy chain,
and the ribosomal subunit L22. Samples in the two right lanes of each blot are recombinant ExoA (rExoA) and control microsomal lysate.
(C) TAP-mediated peptide translocation was assessed with purified phagosomes. Addition of ICP47 (1-35) (closed circles) significantly blocked
peptide transport compared to control cells (open circles). The addition of ExoA alone (open squares) had no significant effect on peptide trans-
location, but significantly reversed ICP47 (1-35)-mediated inhibition of TAP function (closed squares). The graphs show the mean (6 SD) of three
independent experiments.OVA in the presence or absence of ExoA. ExoA com-
pletely inhibited crosspresentation of OVA, measured
by IL-2 secretion by the B3Z hybridoma (Figure 5A).
The inhibition was not due to ExoA toxicity; at the con-
centration used, no inhibition of protein synthesis was
observed (Figure S2). Presentation of exogenously
added SIINFEKL peptide was unaffected by ExoA (Fig-
ure 5B). If ExoA works by blocking antigen translocation
into the cytosol, it should not affect conventional pre-
sentation of cytosolic antigens. To test this, KG1.Kb cells
were transfected with a truncated form of OVA restricted
to the cytosol (KG1.Kb.OVA). Expression of the Kb-SIIN-
FEKL complex by these cells was unaffected by incuba-
tion for 18 hr with concentrations of ExoA sufficient to
impair crosspresentation (Figure 5C). Similarly, expres-
sion of Kb-SIINFEKL complexes in KG1.Kb cells infected
with an OVA-expressing recombinant vaccinia virus
(rVV) was not affected by ExoA (Figure 5D). Surface Kb
expression was comparable for all samples (Figure S3).
Thus, conventional presentation is not compromised by
exogenous ExoA. Overall, the data clearly implicate theER retrotranslocation machinery in the crosspresenta-
tion of exogenous Ags.
Retrotranslocation by Purified Phagosomes
To further characterize the retrotranslocation of Ags
from phagosomes, we established a novel in vitro assay
with the enzyme luciferase as a model substrate (Fig-
ure 6). After incubating KG-1 cells with luciferase in the
presence of latex beads, phagosomes were isolated
and resuspended in intracellular transport buffer (ICT).
They were then incubated in the presence or absence
of cytosol for 30 min. After centrifugation, quantitation
of luciferase activity in the supernatant served as a mea-
sure of export from the phagosomes. Luciferase export
was observed only in the presence of cytosol and was
ATP dependent, being inhibited by inclusion of apyrase
(Figure 6A). The apyrase was conjugated to agarose
beads to facilitate its removal prior to the luciferase as-
say. Comparison of the activities released by cytosol
versus detergent solubilization indicated that approxi-
mately 30% of the total internalized luciferase was
Immunity
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(A) KG1.Kb cells were incubated with 10 mg/ml ExoA (squares) or BSA (circles) for 18 hr in the presence of varying concentrations of exogenous
OVA. Inhibition of OVA crosspresentation was assessed by coculture of these cells with the Kb-SIINFEKL-specific T hybridoma, B3Z. IL-2 pro-
duction was quantitated by ELISA; the values indicate the mean (6 SD) of triplicate samples.
(B) KG1.Kb cells were incubated with either ExoA or BSA in the presence of varying concentrations of SIINFEKL peptide. The ability of these cells
to stimulate B3Z-mediated IL-2 production was assessed by ELISA. The values indicate the mean (6SD) of triplicate samples.
(C and D) Endogenous OVA presentation is unaffected by treatment with ExoA. The generation of the Kb-SIINFEKL epitope by KG1.Kb cells
expressing endogenous OVA (C) or (D) by KG1.Kb cells infected with rVV-OVA (solid lines) or control rVV (dashed gray lines), was examined
by flow cytometric staining with the 25D1.16 mAb after treatment with either ExoA or BSA. In (C), treated samples are indicated by small dashes,
whereas untreated samples are shown as a solid line. The large dashes indicate control staining of OVA-expressing KG-1 cells lacking Kb
expression. All results are representative of at least three independent experiments.specifically exported. To exclude contaminating ER as
the source of the exported luciferase, we prepared
phagosomes from a mixture of KG-1 cells that had inter-
nalized soluble luciferase and KG-1 cells that had
internalized latex beads alone. Under these conditions,
no marked luciferase export was detected (Figure
6A). Thus, purified phagosomes can mediate ATP-
dependent retrotranslocation of an internalized protein
substrate.
Recombinant p97 Restores Phagosome-to-Cytosol
Retrotranslocation
The p97 AAA ATPase forms a hexameric ring that inter-
acts with proteins undergoing sec61-mediated retro-
translocation, and it has been shown to interact with Der-
lin-1, which also is implicated in retrotranslocation from
the ER (Ye et al., 2004). p97 is thought to provide the force
allowing passage through the retrotranslocating channel
(Ye et al., 2003). We added recombinant p97 to phago-
somes to determine whether it could induce luciferase
release (Figure 6B). The addition of ATP-bound, purified
p97 hexameric complexes indeed induced luciferase ex-
port. Retrotranslocation induces hydrolysis of the bound
ATP, and the recombinant p97 therefore cannot perform
repeated rounds of translocation in vitro, although it
clearly functions enzymatically in vivo. Consumption of
active p97 during the in vitro reaction presumably
explains the observed concentration dependence.
A double point mutation in the ATPase sites of p97
renders it unable to release retrotranslocation sub-strates, trapping them within the ER lumen (Ye et al.,
2001). Addition of this dominant-negative form of p97
(DN p97) did not markedly induce luciferase export
from phagosomes (Figure 6B), demonstrating that the
effect of p97 resulted specifically from its ATPase activ-
ity. Inclusion of DN p97 into reactions performed in the
presence of cytosol partially inhibited export, consistent
with its described dominant-negative characteristics
(Figure 6C). The data indicate that p97 is required for ef-
ficient export of a protein substrate from phagosomes,
as it is for retrotranslocation of ERAD substrates from
the ER.
p97 ATPase Activity Is Required
for Crosspresentation
To examine the role of p97 in crosspresentation, KG1.Kb
cells were transiently transfected with constructs encod-
ing either the wild-type (WT) or DN form. These con-
structs were bicistronic and coexpressed enhanced
green fluorescent protein (EGFP), allowing detection of
cells expressing the transfected p97. After incubation
with OVA, cells containing DN p97 (EGFP+), but not the
residual cells (EGFP2), failed to express surface Kb-SIIN-
FEKL complexes (Figure 7A). Expression of WT p97 did
not alter OVA crosspresentation. Constitutive presenta-
tion of the cytoplasmic form of OVA expressed in
KG1.Kb.OVA cells remained unaffected by expression
of either WT or DN p97 (Figure 7B). These data suggest
that DN p97 inhibits a specific step in crosspresentation
prior to the entry of Ags into the classical MHC class I
ERAD Mechanisms and Crosspresentation
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location
(A) Purified luciferase-loaded phagosomes were incubated for 30
min in the absence (column 1) or presence (column 2) of cytosol.
In column 3, apyrase-conjugated beads were added to deplete
ATP and then removed by centrifugation. Columns 4–6 show control
phagosomes, isolated from a mixture of KG-1 cells that had internal-
ized latex beads alone and KG-1 cells that had internalized fluid
phase luciferase, incubated as in columns 1–3. Relative luciferase
activity transported out of phagosomes during the reaction, mea-
sured with a luciferin substrate by luminometry, was normalized to
the total luciferase released upon detergent lysis of phagosomes.
(B) Purified luciferase-loaded phagosomes were incubated with
increasing concentrations of recombinant WT p97 (light gray col-
umns) or DN p97 (dark gray columns) and luciferase export was
measured as in (A). The columns on the right show export with cyto-
sol (black column) or without cytosol (white column). Values are in-
dicated as a percentage of those obtained with cytosol.
(C) Purified luciferase-loaded phagosomes were incubated without
cytosol (white column), with cytosol alone (black column), or with
cytosol plus the indicated concentrations of WT p97 (light gray col-
umns) or DN p97 (dark gray columns), and luciferase export was
measured as in (A). Values are indicated as a percentage of those
obtained with cytosol alone. All graphs show the mean values
(6 SD) derived from four or more independent experiments.loading pathway. This step is likely to be the retrotrans-
location of exogenous Ags into the cytosol.
Discussion
The observation that nascent phagosomes from DCs
and macrophages contain ER membrane components
(Gagnon et al., 2002; Guermonprez et al., 2003) led to
the suggestion that the retrotranslocation mechanisms
involved in ERAD might also introduce exogenous pro-
tein antigens into the cytosol. The ER-mediated phago-
cytosis hypothesis is controversial (Hatsuzawa et al.,
2006; Touret et al., 2005), and this led us to devise a novel
approach to determining whether phagosomes acquire
ER membrane. We were able to demonstrate that an
acceptor peptide physically coupled to a bead can be
glycosylated upon phagocytosis. Although this clearly
shows that the bead is directly accessible to ER luminal
components, it does not address the issue of whether
ER membrane contributes to initial stages of phago-
some formation at the phagocytic cup, as suggested
by Desjardins and coworkers (Gagnon et al., 2002). We
did find that 30 min after phagocytosis was initiated, gly-
cosylation was lost, consistent with proteolysis occur-
ring during maturation into phagolysosomes (data not
shown). This would be predicted by the work from the
Desjardins group.
Data arguing that sec61 is involved in retrotransloca-
tion for ERAD, combined with its observed presence in
phagosomal membranes, implied that it might be in-
volved in crosspresentation (Guermonprez et al., 2003;
Houde et al., 2003). We have shown that exogenous sol-
uble proteins can directly access the ER in DCs (Acker-
man et al., 2005). In this situation, the mechanisms un-
derlying ERAD could obviously provide the means for
exogenous protein antigens to enter the cytosol. The ef-
ficiency with which US6, a TAP inhibitor operating on the
lumenal side, could block TAP in DCs (Ackerman et al.,
2005) suggested that ICP47, operating on the cytosolic
side, could serve as a probe for the retrotranslocation
process involved in crosspresentation. We clearly
show here that functional ICP47 (1-35) can access the
cytosolic face of TAP in DCs. How efficient the process
is cannot be evaluated: endocytic or cytosolic proteoly-
sis of the peptide could compromise the efficiency,
explaining the relatively high concentrations required.
Both phagosomal and ER-associated TAP is impaired
by ICP47 (1-35) addition.
Although the data are consistent with ER-mediated
entry of ICP47 (1-35) into the cytosol, it is conceivable
that retrotranslocation could occur from an endocytic
compartment. However, ExoA, an inhibitor of sec61-
mediated retrotranslocation from the ER, reversed the
ICP47 effect, suggesting that the ER is in fact involved.
It remains possible that, rather than involving the true
ER, retrotranslocation of ICP47 (1-35) occurs from an
endosome or macropinosome that has acquired ER
membrane. Nevertheless, a dominant-negative mutant
of the AAA ATPase p97 that inhibits the sec61-mediated
retrotranslocation pathway could also block crosspre-
sentation, and we could identify a physical interaction
between exogenous ExoA and p97. These data are all
consistent with the involvement of the ERAD mechanism
in crosspresentation. A role for ERAD was also
Immunity
614Figure 7. DN p97 Inhibits Crosspresentation but Not Constitutive Endogenous OVA Presentation
(A) 6 hr after transient transfection with vectors expressing EGFP alone (right) or a combination of EGFP and either WT (left) or DN (middle) p97,
KG1.Kb cells were incubated for 24 hr in the presence of exogenous OVA (bold lines) or BSA (thin lines). Inhibition of OVA crosspresentation was
assessed by flow cytometry with the 25D1.16 mAb. Transfected cells were differentiated from untransfected cells by gating on EGFP expression.
(B) 30 hr after transient transfection of KG1.Kb.OVA cells with the indicated EGFP coexpressing vectors, the generation of the Kb-SIINFEKL epi-
tope was examined by flow cytometry as in (A). EGFP-positive samples are shown as small dashes, while EGFP-negative samples are shown as
a solid line. The large dashes indicate control staining of OVA-expressing KG-1 cells lacking Kb expression. All results are representative of at
least three independent experiments.supported by the work of Imai et al. (2005). Members of
the ribosome-inactivating protein toxin family (cholera
toxin, ExoA, ricin) escape proteasomal degradation
and can be retrotranslocated in a p97-dependent manner
without being ubiquitinated (Abujarour et al., 2005; Ro-
dighieroet al., 2002). Thus, ExoAmay not have to be ubiq-
uitinated to interact with recombinant p97. We have been
able to identify Derlin-1, a recently defined component of
the retrotranslocation apparatus (Lilley and Ploegh,2004;
Ye et al., 2004), in purified phagosomes in association
with p97 and Sec61b (Figure S4). The functional relation-
ship between Sec61 and Derlin-1 is still unclear. We were
unable, however, to definitively demonstrate a direct in-
teraction betweenSec61 and internalizedExoA, although
this has been claimed by others (Koopmann et al., 2000).
In our own experiments, although immunoprecipitation
with sec61 Abs suggested a possible association with
internalized 125I-labeled ExoA, the Abs were poor and
the result was unconvincing (data not shown). Our tech-
niques may be inadequate to detect what is likely to be
a transient interaction.If indeed Sec61 is the retrotranslocon, one may ask
questions about the state of the protein undergoing ret-
rotranslocation. The pore of the archebacterial sec61
complex (Van den Berg et al., 2004) is predicted to be
approximately between 20 and 40 angstroms in diameter
in its open conformation, large enough to transport a
translating polypeptide loop (Eichler and Duong, 2004;
Hamman et al., 1997; Tsai et al., 2002). However, large
proteins, including HLA class I heavy chains, can be
translocated into the cytosol from the ER (Hughes
et al., 1997; Wiertz et al., 1996). Even tightly folded pro-
tein domains can be translocated (Tirosh et al., 2003).
Thus, unfolding of small proteins may be unnecessary.
However, larger proteins may require partial unfolding
to gain access to the cytosol. The retrotranslocation
assay with purified phagosomes uses luciferase, with
a MW of 61 kDa, as a substrate, and it is obviously
enzymatically active after export. Whether this requires
refolding is currently under investigation.
Many mechanistic questions remain regarding ER ret-
rotranslocation, including the relative roles of sec61 and
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factors involved (Ye et al., 2003). Chaperones facilitate
ERAD (Molinari et al., 2002), and protein substrates are
often already partially unfolded. In crosspresentation,
Ags can enter the endocytic pathway as large protein
complexes, or even as whole pathogens. Retrotranslo-
cation for crosspresentation may therefore require un-
foldases, thiol reductases, and proteases not required in
ERAD, perhaps including species restricted to the endo-
cytic pathway. The in vitro reconstitution of phagosomal
retrotranslocation provides a useful system to look for
such cofactors. ATP-bound p97 hexamers can mediate
export, although not as efficiently as complete cytosol.
This may be because additional cofactors are missing.
Multiple cofactors facilitate sec61-mediated retrotrans-
location, including the proteasome (Kalies et al., 2005)
and the p97 binding proteins Ufd1 and Npl4 (Meyer
et al., 2000, 2002). p97 binding to some retrotranslocat-
ing proteins is partially dependent on Ubc6-mediated
ubiquitination (Elkabetz et al., 2004; Flierman et al.,
2003), which may not be efficient in the in vitro assay.
An ER multiprotein complex containing p97, Derlin-1,
and the E3 ligase Hrd1 has recently been described,
further stressing the link between recruitment of ubiqui-
tination machinery and retrotranslocation of ERAD sub-
strates (Lilley and Ploegh, 2005; Ye et al., 2005). The
involvement of ubiquitination and subsequent proteaso-
mal engagement in retrotranslocation from phagosomes
promises to be a productive area for future studies.
Experimental Procedures
Antibodies and Peptides
PE-conjugated anti-HLA-DR and purified and biotinylated 28-8-6S
(anti-Kb,Db) mAbs were obtained from BD Pharmingen. An Alexa
Fluor 647-conjugated mAb specific for Kb-SIINFEKL complexes,
25D1.16 (Porgador et al., 1997), was provided by Dr. Jonathan Yew-
dell (National Institutes of Health, Bethesda, MD). 4E and IG12 are
mAbs specific for HLA-B-C and transferrin receptor, respectively
(Ackerman et al., 2005). A purified rabbit Pseudomonas Exotoxin A
(ExoA) Ab (Sigma) was biotinylated with EZ-link NHS-Biotin (Pierce),
according to the manufacturer’s protocol. Peptides, including ICP47
(1-35) and ICP47 (35-1) (the reverse sequence of ICP47 (1-35)), were
synthesized by the W.M. Keck Foundation Biotechnology Resource
Laboratory at Yale University.
Cells and Cultures
PeCr2 is a human EBV-transformed B cell. PeCr2.Kbcells were gen-
erated by infection of PeCr2 with a retrovirus encoding H2-Kb cDNA.
KG1.Kb.OVA cells were generated from KG1.Kb cells (Ackerman and
Cresswell, 2003) with a retrovirus encoding cytoplasmic OVA as
described (Delamarre et al., 2003). Primary human DCs and macro-
phages were generated (Sallusto and Lanzavecchia, 1994) from
human mononuclear cells isolated via lymphocyte separation me-
dium (LSM, Cellgro) according to the manufacturer’s protocol.
MHC Class I Surface Downregulation by ICP47 (1-35)
Primary DCs, B cells, macrophages, KG-1 cells, and PeCr2 B cells
were incubated with serial dilutions of ICP47 (1-35) or ICP47 (35-1)
in RPMI 1640 supplemented with 20% FCS for 16 hr. After washing,
cells were stained with fluorescein-conjugated mouse anti-HLA-
ABC Ig and examined by flow cytometry. DC, B cell, and macro-
phage purity was confirmed with PE-conjugated antibodies to
CD83, B220, and CD14, respectively. mAbs specific for HLA-DR
and transferrin receptor (TfnR) served as specificity controls.
OVA Presentation
The formation of Kb-SIINFEKL complexes by KG-1.Kb cells was an-
alyzed by flow cytometry with Alexa Fluor 647-conjugated 25-D1.16mAb or with the T cell hybridoma B3Z (Karttunen and Shastri, 1991)
as described (Ackerman et al., 2003). When indicated, Pseudomo-
nas aeruginosa ExoA (Sigma) was added at a final concentration
of 10 mg /ml.
Infection with Recombinant OVA-Expressing Viruses
KG1.Kb and PeCr2.Kb cells were preincubated for 30 min in 100 mM
ICP47 (1-35) or ICP47 (35-1) at 37C and infected with VSV-OVA (pro-
vided by Dr. Leo LeFranc¸ois, University of Connecticut, Farmington,
CT) at a multiplicity of infection (MOI) of 10 for 18 hr in the presence
of the peptides. Cell aliquots were analyzed prior to infection for Kb-
SIINFEKL surface expression and at 1 hr intervals beginning 10 hr
postinfection. KG1.Kb cells were infected with rVV-OVA or a control
rVV at MOI of 10. Kb-SIINFEKL surface expression was monitored
after 9 hr.
Contribution of ER Membranes to Phagosome Formation
A glycosylation acceptor peptide (KAAARRYQNSTELRRYQNSTEL)
or a control peptide (KAAARRYQNSAELRRYQNSAEL) were cou-
pled to carboxylate-modified microspheres (1.0 mm; Molecular
Probes) with 1-ethyl-3(3-dimethylaminopropyl)-carbodiimide ac-
cording to the manufacturer’s protocol. KG-1 cells were incubated
with peptide-coupled microspheres for 15 min in IMDM supple-
mented with 5% BCS, followed by 30 min incubation with 10 mg/ml
cytochalasin D (Sigma). After washing, the cells were lysed in 1%
Triton X-100, and microspheres were separated by centrifugation
and washed in PBS. Glycosylation was detected by flow cytometry
analysis with Con A conjugated to Alexa Fluor 647 (Molecular
Probes). In control experiment, KG-1 cells were incubated with tuni-
camycin (10 mg/ml; Sigma) for 1 hr prior to addition of the coupled
microspheres.
Measurement of TAP-Dependent Peptide Translocation
Phagosomes were purified from 13 108 KG-1 cells after a 15 min in-
cubation with 100 mM ICP47 (1-35) or ICP47 (35-1) in the presence of
100 ml deep blue dyed latex beads (Molecular Probes) as described
(Desjardins et al., 1994; Gagnon et al., 2002). Microsomes were also
isolated from similarly treated KG-1 cells. For analysis of total cellu-
lar TAP activity, the cells were permeabilized with SLO. Peptide
translocation assays were performed on whole cells and purified
cellular compartments by capturing the glycosylated 125I-labeled
glycosylation substrate peptide nef7B on Con A-Sepharose beads
as described (Ackerman et al., 2003).
In Vitro Retrotranslocation Assay
KG-1 cells were cultured with luciferase and 150 ml deep blue dyed
latex beads (0.8 mm; Sigma) for 2 hr. Phagosomes were isolated, re-
suspended in ICT (50 mM HEPES, 78 mM KCl, 4 mM MgCl2, 8.37
mM CaCl2, and 10 mM EGTA), and incubated with or without cyto-
sol for 30 min at 37C. After pelleting the phagosomes, superna-
tants were mixed with luciferin-containing buffer (0.15 mg/ml beetle
luciferin [Promega], 40 mM Tricine [pH 7.8], 0.5 mM ATP, 10 mM
MgSO4, 0.5 mM EDTA, 0.5 mM Coenzyme A [Sigma], 10 mM
DTT), and luciferase activity was assessed with a luminometer (Wal-
lac). Cytosol was generated by dounce-homogenization, clarified
by ultracentrifugation at 120,000 3 g for 1 hr at 4C, and dialyzed
overnight against ICT buffer. Recombinant WT and DN p97 forms
were purified from E. coli as described (Ye et al., 2003). When
indicated, phagosomes and cytosol were preincubated for 30 min
with apyrase-conjugated agarose beads, which were removed by
centrifugation.
Effect of p97 Expression on OVA Presentation
cDNAs encoding WT and DN p97 (gifts of Drs. Hemmo Meyer and
Graham Warren, Yale University) were cloned into pMSCV2.2
EGFP (provided by Dr. David Schatz, Yale University) to create p97
WT pMSCV and p97 DN pMSCV, respectively. This plasmid bicis-
tronically expresses EGFP, allowing the correlation of EGFP and
p97 expression. KG1.Kb and KG1.Kb.OVA cells were transiently
transfected with either p97 WT pMSCV or p97 DN pMSCV by electro-
poration. KG1.Kb cells were allowed to recover for 6 hr prior to 24 hr
incubation in soluble OVA. The formation of Kb-SIINFEKL complexes
was analyzed with Alexa Fluor 647-conjugated 25D1.16 mAb.
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616p97 Association with ExoA in Microsomes
Purified recombinant p97 was biotinylated with EZ-Link Sulfo-NHS-
LC-Biotin (Pierce) as suggested by the manufacturer. Microsomes
were isolated by dounce-homogenization and discontinuous su-
crose gradient ultracentrifugation from 108 KG-1 cells after 2 hr incu-
bation with 30 mg/ml ExoA (Calbiochem), and incubated with biotiny-
lated p97 WT or biotinylated GST as control for 1 hr at 4C. Pelleted
microsomes were resuspended in 0.02 M Bicine, 0.13 M NaCl (pH
8.0), containing 1% digitonin and the crosslinker dithiobis-succini-
midylpriopionate (DSP, 1 mM; Pierce). After 30 min on ice, the reac-
tion was quenched with 20 mM Tris-HCl (pH 7.5), and biotinylated
p97 WT or biotinylated GST were isolated from the supernatants
with streptavidin-Sepharose (high-performance, GE). To exclude
postsolubilization binding, we performed a control experiment in
which biotinylated p97-treated microsomes were mixed with
ExoA-containing microsomes during lysis and crosslinking. For all
samples, coprecipitated ExoA was detected by reducing SDS-
PAGE and immunoblotting with rabbit anti-ExoA IgG and alkaline
phosphatase-conjugated secondary antibody (Jackson ImmunoRe-
search) and ECF substrate (GE). Control blotting was performed with
3B10.7 monoclonal MHC-I and monoclonal L22 antibodies (Acker-
man et al., 2003).
Supplemental Data
Four Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/4/607/DC1/.
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